Adverse reactions to immunotherapy are associated with different patterns of sensitization to grass allergens

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 5, 2015, Pages 598-600

  Sastre, Joaquín ^a   Rodriguez F ^b   Campo, P ^c   Laffond, E ^d   Marin A ^e   Alonso, M D ^f  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^e ALK ABELLÓ   (Denmark)

^f HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

grass allergens; immunotherapy; molecular diagnosis; safety

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; PHLEUM PRATENSE EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; ASTHMA; CONJUNCTIVITIS; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHLEUM PRATENSE; PRIORITY JOURNAL; RHINITIS; SENSITIZATION; ADOLESCENT; ADVERSE EFFECTS; CLINICAL TRIAL; DESENSITIZATION; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; MULTICENTER STUDY; POACEAE; POLLEN ALLERGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; POACEAE; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 84926416292     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12575     Document Type: Article

References (10)

1. Sastre J,. Molecular diagnosis in allergy. Clin Exp Allergy 2010; 40: 1442-1460.
2. 2LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 2013; 6: 17.
3. Sastre J,. Molecular diagnosis and immunotherapy. Curr Opin Allergy Clin Immunol 2013; 13: 646-650.
4. Sastre J, Landivar ME, Ruiz-García M, Andregnette-Rosigno MV, Mahillo I,. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy 2012; 67: 709-711.
5. Muller U, Schmid-Grendelmeier P, Hausmann O, Helbling A,. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy. Allergy 2012; 67: 1069-1073.
6. 2 LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy 2010; 65: 1525-1530.
7. Barber D, de la Torre F, Feo F, Florido F, Guardia P, Moreno C., et al. Understanding patient sensitization profiles in complex pollen areas: a molecular epidemiological study. Allergy 2008; 63: 1550-1558.
8. Huertas AJ, Carreño A, Mérida C, Pajarón-Fernández MJ, Ramírez-Hernández M, Carnés J,. Profilin sensitisation in a Mediterranean population. Allergol Immunopathol (Madr) 2014; 42: 387-394.
9. Pfaar O, Jung K, Wolf H, Decot E, Kleine-Tebbe J, Klimek L, et al. Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio. Allergy 2012; 67: 630-637.
10. Darsow UL, Brockow K, Pfaa F, Jakob T, Petersson CJ, Borres MP, et al. Heterogeneity of molecular sensitization profiles in grass pollen allergy-implications for immunotherapy?: allergens. Clin Exp Allergy 2014; 44: 778-786.